Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
How epilepsy risks might be introduced and discussed in clinical consultations
Cordet Smart1, Hannah Cock2, Phil Tittensor3
1Director of Professional Doctorates and Clinical Associate Psychology, Exeter University, United Kingdom.
Discussing epilepsy risks like Sudden Unexpected Death from Epilepsy (SUDEP) is challenging. Clinicians should tailor risk discussions to patient understanding, but directness is often preferred for better engagement in managing epilepsy risks.
Area of Science:
- Neurology
- Medical Communication
- Qualitative Research
Background:
- Adverse impacts of epilepsy, including injury, depression, and Sudden Unexpected Death from Epilepsy (SUDEP), can be mitigated through patient-controlled factors.
- New guidelines recommend discussing risks at diagnosis, but clinicians hesitate due to potential patient anxiety.
Purpose of the Study:
- To analyze how expert epilepsy clinicians initiate discussions about risks with patients in specialist clinics.
- To understand the communication strategies employed during these sensitive conversations.
Main Methods:
- Conversation Analysis of 24 initial telephone appointments at specialist epilepsy clinics in England.
- Inclusion of a case study and joint-analysis sessions with clinicians, researchers, and patients.
Main Results:
- Broaching epilepsy risk is sensitive and complex, involving negotiation and addressing patient confusion.
- Clinicians use questioning and 'repair implicative' techniques to build intersubjectivity.
- Epistemic factors (who knows what) are crucial in these discussions.
Conclusions:
- Clinicians often use patient knowledge as a basis for discussing behavior change, avoiding direct mention of severe risks.
- This approach can cause interactional difficulties, with patients preferring more direct communication.
- Careful calibration of risk information and directness are key for patient engagement in epilepsy risk management.
More Related Videos
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
10:46Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Electroconvulsive Therapy
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...